Thus - although the causative role of galectin-3 and sST2 is not proved in the pathogenesis of SSc - we hypothesized that circulating biomarkers of the cardiac fibrosis may be useful in screening and early diagnosis of the cardiac manifestation in this disease. The gene discussed is LGALS3; the disease is systemic sclerosis.